Me. Spurlock et al., REGULATION OF ADIPSIN AND BODY-COMPOSITION IN THE MONOSODIUM GLUTAMATE (MSG)-TREATED MOUSE, Physiology & behavior, 60(5), 1996, pp. 1217-1221
Changes in food intake, serum adipsin, and obesity were evaluated in t
he MSG-treated mouse. In Experiment 1, mice treated with MSG had 50% l
ower serum adipsin and over 2-fold higher percentage of body fat than
the lean controls. Both feeding caffeine and restricting intake normal
ized serum adipsin and caused weight loss, but did not normalize the p
ercentage of body fat. No additional effect was gained by feeding isop
roterenol or ephedrine in combination with caffeine. In Experiment 2,
we separated the direct effect of caffeine from the associated depress
ion in intake using a paired feeding design, and also determined the e
ffects of selected adrenergic agents and somatotropin (S). Somatotropi
n increased weight gain and reduced the percentage of body fat in heal
thy and obese mice, and tended to lower serum adipsin. Caffeine clearl
y depressed intake, caused weight loss, and increased serum adipsin, b
ut similar results were achieved by restricting intake. None of the ad
renergic drugs tested changed serum adipsin. Ephedrine depressed food
intake and caused weight loss, but reduced the percentage of body fat
only at the highest dietary concentration (2000 mg per kg of diet). Ph
enylephrine reduced weight gain without a concomitant effect on the pe
rcentage of body fat, and isoproterenol did not influence weight gain
or body fat. Copyright (C) 1996 Elsevier Science Inc.